glp-1 drugs oral Eli Lilly Gets Speedy FDA Nod for Drug, a Competitor to New Novo Nordisk Pill A new oral GLP-1 medication
Description
In contrast with DPP-4 inhibitors, GLP-1RAs have attracted attention because a weight loss effect appears when the dose of this drug is increased [23]
A recent meta-analysis including data from SURMOUNT-1, a trial conducted in individuals with obesity, confirmed the favorable effects of tirzepatide on dyslipidemia, finding a 16 and 13.7% change from baseline in triglycerides and very low-density lipoproteins with tirzepatide 15 mg vs
SHOP THE EXPERTS' PICKS Artah, Beauty Pie, Sigrid, Dr
Gaede, P
